missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ GLYX 13
NMDA receptor partial agonist; acts at the glycine site
Marke: Tocris Bioscience™ 3406/1
195.66 CHF gültig bis 2024-12-16
Benutzen Sie den Promotions-Code "21630" um Ihren Promotions-Preis zu erhalten.
Dieser Artikel kann nicht zurückgegeben werden.
Rückgaberichtlinie anzeigen
Beschreibung
GLYX 13 is a NMDA receptor partial agonist that acts at the glycine site. Simultaneously acts as a promoter of the induction of long-term potentiation (LTP) and as a suppressor of long-term depression (LTD). Also promotes VGF and BDNF release and increases ERK/mTOR signaling . Exhibits nootropic, neuroprotective and antinociceptive activity, and enhances learning, memory and cognition in vivo. Brain penetrant.Spezifikation
| 0.95 | |
| 1 mg |